What Is Suboxone?

Suboxone is one of the medications that treat opioid use disorder, and the questions around it sit in the details: how the first dose is timed, how long treatment runs, and who pays for the film. The answers rest on the prescribing information, federal rules and the research on overdose risk, and they are worth having before a first appointment.

What Is Suboxone?

Suboxone is the brand name of a prescription sublingual film, held under the tongue or tucked between the cheek and gum until it dissolves. It pairs buprenorphine with naloxone, and it is approved to treat opioid dependence when it is used alongside counseling and support. The Food and Drug Administration (FDA) approved the brand in 2002 and the film in 2010.

Buprenorphine is a partial opioid agonist, so it settles onto the receptors other opioids act on without switching them on all the way. The Suboxone label places the combination in Schedule III of the Controlled Substances Act, and the Drug Enforcement Administration (DEA) fact sheet on buprenorphine puts every buprenorphine product at the same schedule.

The approved use is opioid use disorder, which the label words as opioid dependence. Buprenorphine products made for pain, among them a patch and a film worn inside the cheek, are a separate group.

Generic buprenorphine-naloxone films and tablets are also sold, and Zubsolv is another brand built on the same two drugs. Each of those products stays in the mouth until it dissolves.

How Does Suboxone Work?

Buprenorphine, the opioid medication in Suboxone, settles onto the same receptors in the brain that other opioids target, but it switches them on only partway. That partial activation is enough to ease withdrawal and cravings, and it means the drug’s opioid effects level off at higher doses instead of climbing. While it occupies those receptors, another opioid taken at the same time produces less effect or none.

Medications that act at these receptors fall into three groups:

The naloxone in the film matters mainly when someone tries to inject it. When injected by a person dependent on a full agonist such as heroin or methadone, Suboxone is likely to produce withdrawal signs and symptoms. Naloxone is added to the combination partly to make the medication a poor choice to inject. The same drug is sold as Narcan nasal spray, which reverses an opioid overdose. Half-life, the time it takes for half of a drug to leave the body, runs 24 to 42 hours for buprenorphine and 2 to 12 hours for naloxone.

What Suboxone Treatment Looks Like

Treatment tends to move in three stages: a supervised start, a stretch of dose adjustment until withdrawal and cravings are under control, and ongoing maintenance with regular check-ins, usually alongside counseling and recovery support.

The start leaves the least room for guesswork. The Suboxone prescribing information advises starting induction once withdrawal is plainly and objectively present, since dosing while a full opioid agonist remains active can set off precipitated withdrawal, where symptoms come on suddenly and severely. With fentanyl, timing is harder to judge, so clinicians may use other approaches.

Maintenance is quieter: scheduled visits, refills, drug testing and counseling, with counseling offered rather than required. The 2024 federal rule for opioid treatment programs untied it from access to medication.

Care happens in a doctor’s or nurse practitioner’s office, by telehealth, at an opioid treatment program, or within residential rehab, an intensive outpatient program or a partial hospitalization program. Induction follows the same rule for any buprenorphine treatment in those settings.

How to Get a Suboxone Prescription

A specially certified prescriber is no longer required. Any clinician whose Drug Enforcement Administration (DEA) registration covers Schedule III drugs may prescribe Suboxone for opioid use disorder (OUD), whether in person or through telehealth, as long as state law permits.

That certification, the X-waiver, ended with the Consolidated Appropriations Act, 2023.

Telehealth has its own limits. A DEA rule effective Dec 31, 2025 allows up to six months of buprenorphine by video or audio-only visit, after a check of the prescription drug monitoring program (PDMP). Beyond that, the prescriber needs a different telemedicine route or a face-to-face visit. Wider telehealth flexibilities remain through Dec 31, 2026.

Care can start at a primary care practice, an addiction medicine clinic, a telehealth service, an opioid treatment program (OTP), or a rehab program.

FindTreatment.gov lists programs, and the SAMHSA National Helpline can talk through options.

Does Suboxone Treatment Work?

Buprenorphine, the medication in Suboxone, is linked in research to two outcomes that matter to someone with opioid use disorder (OUD): a lower risk of dying of an overdose and a better chance of staying in treatment.

Larochelle and colleagues found in 2018 that among people who had survived a nonfatal overdose, buprenorphine treatment came with a 38% lower risk of dying of an opioid overdose.

Most people with OUD still do not get one. In 2025, 15.7% of people aged 12 and older with OUD received medication for it, or 623,000 people, according to the National Survey on Drug Use and Health (NSDUH) from SAMHSA.

Common Myths About Suboxone

Being physically dependent on a prescribed medicine is not the same as having an addiction, and federal guidance places people who take medication for opioid use disorder (OUD) in recovery. Four beliefs run against it.

Any of these beliefs is worth putting to the prescriber, who can explain the reasoning behind a plan.

Is Suboxone Safe? Side Effects and Warnings

Suboxone is approved by the US Food and Drug Administration (FDA) for opioid use disorder and widely prescribed. It can cause side effects, and breathing can slow dangerously when it is taken alongside a benzodiazepine, another sedative or alcohol.

Headache, nausea and vomiting are common, along with sweating, constipation, trouble sleeping, and numbness or pain in the mouth.

Very slow or shallow breathing is an emergency, so call 911. Alcohol and other sedatives raise that risk. The FDA says medication for opioid use disorder should not be withheld for someone who also uses them, though the mix needs careful management. Keep it out of a child’s reach.

The warnings also list liver problems. In 2022 the FDA advised people using buprenorphine medicines to sip water, swish it in the mouth and swallow after the film dissolves, and wait 1 hour before brushing their teeth.

The Centers for Disease Control and Prevention (CDC) recommends methadone or buprenorphine for pregnant people with opioid use disorder, and neonatal opioid withdrawal syndrome (NOWS) is expected and treatable.

Suboxone vs. Subutex, Zubsolv and Injections

Suboxone belongs to a small family of buprenorphine medications for opioid use disorder. What separates the members is whether naloxone is in the product and how the dose is taken.

Related articleBuprenorphine Treatment for Opioid Use Disorder (2025 Update)Buprenorphine treatment can ease withdrawal and cravings by partly switching on opioid receptors, and the effect stops climbing at higher doses. Timing the first dose matters too, because taking it…Nikki Wisher12 min readUpdated Oct 30, 2026

The FDA’s list of medications for opioid use disorder sets out each product and its route:

The injections carry conditions the tablets and films do not. Their prescribing information places Sublocade and Brixadi under a risk evaluation and mitigation strategy (REMS), requirements a prescriber and a pharmacy have to meet before the drug is dispensed. Every product here is a form of buprenorphine treatment; the differences are ingredients and route, not the condition treated. Buprenorphine-only tablets were sold as Subutex before generics replaced the brand, and misuse of that product is covered under Subutex misuse.

How Long Do People Stay on Suboxone?

Suboxone has no fixed finish line. Its prescribing information sets no maximum recommended length for maintenance treatment, and some people may need the medication indefinitely. Many do better with a year or more than a short course, and stopping is a decision to make with the prescriber, not on a calendar.

Castro and colleagues, in a 2026 American Family Physician review, recommend at least 12 months of buprenorphine maintenance before a taper starts, with a slow, individualized taper. Medication for opioid use disorder can be taken on a short- or long-term basis, as medically supervised withdrawal or as maintenance treatment.

The weeks after a last dose carry their own risk. Overdose and acute care after treatment ended were common across the durations examined. Naloxone reverses an opioid overdose, and a prescriber can say what to do if one happens.

Does Insurance Cover Suboxone?

Most plans pay for it. Medicaid pays for opioid use disorder medication in every state, Medicare covers buprenorphine, and most private plans cover it too, sometimes after prior authorization.

The Centers for Medicare & Medicaid Services (CMS) has made that Medicaid coverage permanent for state programs. Part B covers buprenorphine given in a doctor’s office or an opioid treatment program (OTP) enrolled with Medicare, with no copayment at those programs and the Part B deductible still applying. Part D may cover it too.

Marketplace plans must include substance use disorder treatment in their essential health benefits, and parity rules require a plan that covers mental health or addiction care to cover it like medical care.

What is left to pay depends on the plan. A benefits check settles it before intake, and someone without coverage can ask a program about a sliding scale.

Frequently Asked Questions About Suboxone